AstraZeneca (AZN) to Join Nasdaq-100 Index

(Updated - February 10, 2022 5:02 PM EST)

Nasdaq today announced that AstraZeneca PLC – ADR (Nasdaq: AZN), will become a component of the NASDAQ-100 Index® and the NASDAQ-100 Equal Weighted Index prior to market open on Tuesday, February 22, 2022. AstraZeneca PLC – ADR will replace Xilinx, Inc. in the NASDAQ-100 Index® and the NASDAQ-100 Equal Weighted Index.

For more information about the company, go to https://www.astrazeneca.com.

You May Also Be Interested In

• ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated statistically significant and clinically meaningful improvement in PFS as 1st-line treatment of patients with HER2-mutant advanced non-small ce
• Reddit (RDDT) added to S&P 500
• U.S. mulls smaller military presence in Gulf once war ends - WaPo